Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688016 Shanghai MicroPort Endovascular MedTech (Group) Co Ltd SHSE:688016
95 GF Score
Price ¥92.86
GF Value ¥123.21
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai MicroPort Endovascular MedTech (Group) Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Shanghai MicroPort Endovascular MedTech (Group) Co Quality Rank Related Terms

SHSE:688016
95GF Score
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd SHSE:688016
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai MicroPort Endovascular MedTech (Group) Co stock appears to be undervalued. The current stock price of ¥92.86 is trading 24.6% below its estimated GF Value™ of ¥123.21. GuruFocus considers Shanghai MicroPort Endovascular MedTech (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:688016:

  • Quality Rank:
  • GF Value™: ¥123.21 vs. price of ¥92.86 (24.6% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai MicroPort Endovascular MedTech (Group) Co Business Description

Address No. 1 Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 201318
Shanghai Microport Endovascular Medtech Co Ltd is engaged in the Research, development, production and sales of interventional medical devices for the aorta and peripheral blood vessels.
95GF Score

Get the complete analysis for SHSE:688016

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥92.86
Price
¥123.21
GF Value